Your RMR drops disproportionately
Your doctor may adjust your dose based on these results to ensure optimal control of your condition
The Lifetime risk of developing thyroid cancer is about 1.1% for Men and 2.5% for women (Pellegriti et al
Gastrointestinal Integrity and Mucosal Protection Models Because BPC-157 was originally identified as a gastric pentadecapeptide, gastrointestinal biology remains a central focus of its experimental literature
GLP-1 medications are not prescribed for patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, during pregnancy or breastfeeding or when pregnancy is planned in the near term, with active pancreatitis or a history of pancreatic disease, or with severe gastroparesis or a significant gastrointestinal motility disorder
If you are a patient at Primary Care Center of Clear Lake and have reached a weight loss plateau while using Wegovy (semaglutide), you may be wondering if switching to Zepbound (tirzepatide) could help you continue your progress